Magnetar Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Magnetar Financial's NVO Position: Q2 2026 in Review
Magnetar Financial increased its Novo Nordisk (NVO) stake by 4.9% in Q2 2026, buying an estimated $12.5K and bringing the position to 6,187 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #789.
Magnetar Financial first reported a position in NVO in Q4 2018 and has held it in 14 quarters since. The position peaked at $53.6M in Q2 2022. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Magnetar Financial held 6,187 shares of Novo Nordisk worth $297K as of Q2 2026.
- Magnetar Financial bought 290 Novo Nordisk shares in Q2 2026, an estimated $12.5K.
- Novo Nordisk made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #789 holding.
- Magnetar Financial first reported a position in Novo Nordisk in Q4 2018 and has held it in 14 quarters since.
- Magnetar Financial's Novo Nordisk position peaked at $53.6M in Q2 2022.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.